Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous COCs Bleeding Patterns Study
NCT00120913Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of avatrombopag, norethisterone acetate and ethinyl estradiol in pregnancy (4 arms), sponsored by Oregon Health & Science University. Primary endpoint: Bleeding patterns at 180 days. Status: completed.
02
Drugs
avatrombopagnorethisterone acetateethinyl estradiol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00120913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120913.